162 related articles for article (PubMed ID: 28713639)
1. A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's Disease.
Ra JC; Jeong EC; Kang SK; Lee SJ; Choi KH
Cell Med; 2017; 9(3):87-102. PubMed ID: 28713639
[TBL] [Abstract][Full Text] [Related]
2. Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy.
Gupta PK; Krishna M; Chullikana A; Desai S; Murugesan R; Dutta S; Sarkar U; Raju R; Dhar A; Parakh R; Jeyaseelan L; Viswanathan P; Vellotare PK; Seetharam RN; Thej C; Rengasamy M; Balasubramanian S; Majumdar AS
Stem Cells Transl Med; 2017 Mar; 6(3):689-699. PubMed ID: 28297569
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
[TBL] [Abstract][Full Text] [Related]
4. Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease.
Gupta PK; Dutta S; Kala S; Nekkanti M; Desai SC; Mahapatra SS; Dhar A; Raju R; M R; Behera A; P S; Raviraja NS; Viswanathan P; Chandrashekar M; Thej C; K V P; Abraham J; Boggarapu H; Udaykumar K
Stem Cells Transl Med; 2021 Dec; 10(12):1602-1613. PubMed ID: 34519179
[TBL] [Abstract][Full Text] [Related]
5. Early Results of Clinical Application of Autologous Whole Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia with Buerger's Disease.
Heo SH; Park YS; Kang ES; Park KB; Do YS; Kang KS; Kim DI
Sci Rep; 2016 Jan; 6():19690. PubMed ID: 26791280
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
[TBL] [Abstract][Full Text] [Related]
7. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model.
Kim SW; Han H; Chae GT; Lee SH; Bo S; Yoon JH; Lee YS; Lee KS; Park HK; Kang KS
Stem Cells; 2006 Jun; 24(6):1620-6. PubMed ID: 16497946
[TBL] [Abstract][Full Text] [Related]
8. Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial.
Lee WS; Kim HJ; Kim KI; Kim GB; Jin W
Stem Cells Transl Med; 2019 Jun; 8(6):504-511. PubMed ID: 30835956
[TBL] [Abstract][Full Text] [Related]
9. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.
Isner JM; Baumgartner I; Rauh G; Schainfeld R; Blair R; Manor O; Razvi S; Symes JF
J Vasc Surg; 1998 Dec; 28(6):964-73; discussion 73-5. PubMed ID: 9845647
[TBL] [Abstract][Full Text] [Related]
10. The Wound Healing Effects of Iloprost in Patients with Buerger's Disease: Claudication and Prevention of Major Amputations.
Afsharfard A; Mozaffar M; Malekpour F; Beigiboroojeni A; Rezaee M
Iran Red Crescent Med J; 2011 Jun; 13(6):420-3. PubMed ID: 22737505
[TBL] [Abstract][Full Text] [Related]
11. Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.
Melian EB; Goa KL
Drugs; 2002; 62(1):107-33. PubMed ID: 11790158
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Angiogenesis by Autologous Transplantation of Bone Marrow Mononuclear Cells for Buerger's Patients with Retractable Limb Ischaemia: A Preliminary Report.
Akar R; Durdu S; Arat M; Eren NT; Arslan Ö; Çorapçıoğlu T; Sancak T; Uzun B; Kİr M; İlhan O; Özyurda Ü
Turk J Haematol; 2004 Mar; 21(1):13-21. PubMed ID: 27263642
[TBL] [Abstract][Full Text] [Related]
13. Successful lumbal sympathetic block as an alternative therapy for improving Buerger's disease: A rare case report and literature review.
Hatta H; Setiawan E; Triani ZD; Rifardi D
Int J Surg Case Rep; 2023 Sep; 110():108778. PubMed ID: 37666157
[TBL] [Abstract][Full Text] [Related]
14. Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease.
Saito Y; Sasaki K; Katsuda Y; Murohara T; Takeshita Y; Okazaki T; Arima K; Katsuki Y; Shintani S; Shimada T; Akashi H; Ikeda H; Imaizumi T
Circ J; 2007 Aug; 71(8):1187-92. PubMed ID: 17652879
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study.
Kumar H; Ha DH; Lee EJ; Park JH; Shim JH; Ahn TK; Kim KT; Ropper AE; Sohn S; Kim CH; Thakor DK; Lee SH; Han IB
Stem Cell Res Ther; 2017 Nov; 8(1):262. PubMed ID: 29141662
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.
Matoba S; Tatsumi T; Murohara T; Imaizumi T; Katsuda Y; Ito M; Saito Y; Uemura S; Suzuki H; Fukumoto S; Yamamoto Y; Onodera R; Teramukai S; Fukushima M; Matsubara H;
Am Heart J; 2008 Nov; 156(5):1010-8. PubMed ID: 19061721
[TBL] [Abstract][Full Text] [Related]
17. Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model.
Zhao W; Zhang C; Jin C; Zhang Z; Kong D; Xu W; Xiu Y
Eur Urol; 2011 Jan; 59(1):155-63. PubMed ID: 21050657
[TBL] [Abstract][Full Text] [Related]
18. [Autologous bone marrow-derived stem cell therapy in patients with severe peripheral arterial disorder].
Boda Z; Udvardy M; Farkas K; Tóth J; Jámbor L; Soltész P; Rázsó K; Oláh Z; Ilonczai P; Szarvas M; Litauszky K; Hunyadi J; Sipos T; Kappelmayer J; Veréb Z; Rajnavölgyi E
Orv Hetil; 2008 Mar; 149(12):531-40. PubMed ID: 18343769
[TBL] [Abstract][Full Text] [Related]
19. Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial.
Pers YM; Rackwitz L; Ferreira R; Pullig O; Delfour C; Barry F; Sensebe L; Casteilla L; Fleury S; Bourin P; Noël D; Canovas F; Cyteval C; Lisignoli G; Schrauth J; Haddad D; Domergue S; Noeth U; Jorgensen C;
Stem Cells Transl Med; 2016 Jul; 5(7):847-56. PubMed ID: 27217345
[TBL] [Abstract][Full Text] [Related]
20. Effect of Folic Acid therapy on Homocysteine Level in patients with Atherosclerosis or Buerger's Disease and in Healthy individuals: A clinical trial.
Modaghegh MH; Ravari H; Haghighi MZ; Rajabnejad A
Electron Physician; 2016 Oct; 8(10):3138-3143. PubMed ID: 27957316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
